Compare · CVRX vs MDLN
CVRX vs MDLN
Side-by-side comparison of CVRx Inc. (CVRX) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CVRX and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $59.42B, about 293.9x CVRX ($202.2M).
- Over the past year, CVRX is up 1.9% and MDLN is up 11.0% - MDLN leads by 9.1 points.
- CVRX has been more active in the news (6 items in the past 4 weeks vs 5 for MDLN).
- MDLN has more recent analyst coverage (25 ratings vs 13 for CVRX).
PerformanceCVRX-4.14%MDLN+10.96%
2025-12-17+0.00%2026-04-27
- Company
- CVRx Inc.
- Medline Inc.
- Price
- $7.65-0.78%
- $45.22+0.99%
- Market cap
- $202.2M
- $59.42B
- 1M return
- -17.83%
- +7.14%
- 1Y return
- +1.86%
- +10.96%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2025
- News (4w)
- 6
- 5
- Recent ratings
- 13
- 25
Latest CVRX
- CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
- CVRx Announces Nomination of Michael Dale for Election to the Board of Directors
- SEC Form DEFA14A filed by CVRx Inc.
- SEC Form DEF 14A filed by CVRx Inc.
- CVRx Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- CVRx Reports Preliminary First Quarter 2026 Financial Results
- Chief Medical Officer Adamson Philip B. was granted 41,000 shares and sold $9,973 worth of shares (1,262 units at $7.90), increasing direct ownership by 182% to 61,578 units (SEC Form 4)
- CHIEF HUMAN RESOURCES OFFICER Morrison Gregory was granted 34,000 shares (SEC Form 4)
- SEC Form 3 filed by new insider Morrison Gregory
- PRES & CEO Hykes Kevin sold $61,349 worth of shares (7,763 units at $7.90) and was granted 159,000 shares, increasing direct ownership by 114% to 284,237 units (SEC Form 4)
Latest MDLN
- SEC Form DEFA14A filed by Medline Inc.
- SEC Form DEF 14A filed by Medline Inc.
- Medline announces first-in-healthcare AI robotics partnership with Symbotic
- Medline to report first quarter 2026 results on May 6, 2026
- Medline launches custom product fulfillment technology called Pick Pack Pro™
- Medline recognizes manufacturing facilities with Golden Cone Safety Award
- Medline receives HIRC Member Choice Awards for supply chain achievement and renews Transparency Badge distinction
- Director Healy Patrick J acquired 577,510 shares, increasing direct ownership by 73% to 1,208,159 units (SEC Form 4)
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,058,524,148 worth of shares (26,131,237 units at $40.51) and disposed of 2,088,086 shares (SEC Form 4)
- Large owner Cp Circle Ml Holdco Gp, Llc sold $1,070,339,440 worth of shares (26,105,840 units at $41.00) and disposed of 2,113,483 shares (SEC Form 4)